Uncovered research trends

Genomic Cancer Testing Market  Market Overview: The Genomic Cancer Testing market is estimated to be valued at US$16.15 billion in 2023, witnessing a significant growth rate of 16.1% over the forecast period of 2023-2030. This market is poised for substantial expansion, revolutionizing the field of cancer diagnostics and treatment. Genomic cancer testing involves the analysis of genetic material to identify specific DNA alterations that can contribute to the development of cancer. The testing enables personalized treatment plans, predicts therapeutic response, and aids in early cancer detection. The use of genomic testing is fueled by the rising prevalence of cancer and the growing demand for targeted therapies. With technological advancements and reduced costs, genomic cancer testing is expected to become mainstream, transforming cancer care globally. Market Dynamics: The Genomic Cancer Testing market is driven by two key factors. Firstly, the increasing incidence of cancer worldw...